Rational Design of Amphipathic α-Helical and Cyclic β-Sheet Antimicrobial Peptides: Specificity and Therapeutic Potential

Peptide Drug Discovery and Development: Translational Research in Academia and Industry

Volumn , Issue , 2011, Pages 91-117

  Hartsock, Wendy J ^a   Hodges, Robert S ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Amphipathic helical AMPs; Antimicrobial peptide (AMP); Commercialization of AMPs; Cyclic sheet AMPs; Specificity; Therapeutic potential

Indexed keywords

EID: 84887187828     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527636730.ch4     Document Type: Chapter

References (46)

1. Boucher, H.W.,Talbot, G.H., Bradley, J.S., Edwards, J.E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., and Bartlett, J. (2009) Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin. Infect. Dis., 48, 1-12.
2. Rice, L.B. (2008) Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J. Infect. Dis., 197, 1079-1081.
3. Maragakis, L.L. (2010) Recognition and prevention of multidrug-resistant Gramnegative bacteria in the intensive care unit. Crit. Care Med., 38, S345-S351.
4. Ho, J., Tambyah, P.A., and Paterson, D.L. (2010) Multiresistant Gram-negative infections: a global perspective. Curr. Opin. Infect. Dis., 23, 546-553.
5. Falagas, M.E. and Kasiakou, S.K. (2005) Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin. Infect. Dis., 40, 1333-1341.
6. Falagas, M.E. and Rafailidis, P.I. (2008) Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives. Expert Opin. Investig. Drugs, 17, 973-981.
7. Anderluh, G. and Lakey, J. (Eds.) (2010) Proteins: membrane binding and pore formation. Austin, Texas, Landes Bioscience. Advances in Experimental Medicine and Biology, 677, 1-167.
8. Kindrachuk, J. and Napper, S. (2010) Structure-activity relationships of multifunctional host defence peptides. Mini Rev. Med. Chem., 10, 596-614.
9. Hodges, R.S., Jiang, Z., Whitehurst, J., and Mant, C.T. Development of antimicrobial peptides as therapeutic agents, in Development of Therapeutic Agents, Handbook in Pharmaceutical Sciences (eds Gad, S. and Eventhal, M.), John Wiley and Sons, in press.
10. Shafer, W.M. (2006) SpringerLink (Online service). Antimicrobial peptides and human disease, in Current Topics in Microbiology and Immunology, Springer-Verlag, Berlin, Heidelberg.
11. Palffy, R., Gardlik, R., Behuliak, M., Kadasi, L., Turna, J., and Celec, P. (2009) On the physiology and pathophysiology of antimicrobial peptides. Mol. Med., 15, 51-59.
12. Guani-Guerra, E., Santos-Mendoza, T., Lugo-Reyes, S.O., and Teran, L.M. (2010) Antimicrobial peptides: general overview and clinical implications in human health and disease. Clin. Immunol, 135, 1-11.
13. Chen, Y., Mant, C.T., Farmer, S.W., Hancock, R.E.W., Vasil, M.L., and Hodges R.S. (2005) Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index. J. Biol. Chem., 280, 12316-12329.
14. Chen, Y., Vasil, A.I., Rehaume, L., Mant, C.T., Burns, J.L., Vasil, M.L., Hancock, R.E.W., and Hodges, R.S. (2006) Comparison of biophysical and biologic properties of alpha-helical enantiomeric antimicrobial peptides. Chem. Biol. Drug Des., 67, 162-173.
15. Chen, Y., Guarnieri, M.T., Vasil, A.I., Vasil, M.L., Mant, C.T., and Hodges, R. S. (2007) Role of peptide hydrophobicity in the mechanism of action of alphahelical antimicrobial peptides. Antimicrob. Agents Chemother., 51, 1398-1406.
16. Jiang, Z., Kullberg, B.J., van der Lee, H., Vasil, A.I., Hale, J.D., Mant, C.T., Hancock, R.E.W., Vasil, M.L., Netea, M. G., and Hodges, R.S. (2008) Effects of hydrophobicity on the antifungal activity of alpha-helical antimicrobial peptides. Chem. Biol. Drug Des., 72, 483-495.
17. Jiang, Z., Vasil, A.I., Hale, J.D., Hancock, R.E.W., Vasil, M.L., and Hodges, R.S. (2008) Effects of net charge and the number of positively charged residues on the biological activity of amphipathic alpha-helical cationic antimicrobial peptides. Biopolymers, 90, 369-383.
18. Jiang, Z., Higgins, M.P., Whitehurst, J., Kisich, K.O., Voskuil, M.I., and Hodges, R.S. (2010) Anti-tuberculosis activity of-helical antimicrobial peptides: de novo designed L-and D-enantiomers versus L-and D-LL-. Protein Pept. Lett., in press.
19. Jiang, Z., Vasil, A.I., Gera, L., Vasil, M. L., and Hodges, R.S. (2010) Rational design of-helical antimicrobial peptides to target Gram-negative pathogens, Acinetobacter baumannii and Pseudomonas aeruginosa: utilization of charge, "specificity determinants", total hydrophobicity, hydrophobe type and location as design parameters to improve therapeutic ratio. Chem. Biol. Drug Des., Submitted.
20. Ehrenstein, G. and Lecar, H. (1977) Electrically gated ionic channels in lipid bilayers. Q Rev. Biophys., 10, 1-34.
21. Mor, A. and Nicolas, P. (1994) The NH2-terminal alpha-helical domain 1-18 of dermaseptin is responsible for antimicrobial activity. J. Biol. Chem., 269, 1934-1939.
22. Matsuzaki, K., Murase, O., Fujii, N., and Miyajima, K. (1995) Translocation of a channel-forming antimicrobial peptide, magainin 2, across lipid bilayers by forming a pore. Biochemistry, 34, 6521-6526.
23. Matsuzaki, K., Murase, O., Fujii, N., and Miyajima, K. (1996) An antimicrobial peptide, magainin 2, induced rapid flipflop of phospholipids coupled with pore formation and peptide translocation. Biochemistry, 35, 11361-11368.
24. Ludtke, S.J., He, K., Heller, W.T., Harroun, T.A., Yang, L., and Huang, H. W. (1996) Membrane pores induced by magainin. Biochemistry, 35, 13723-13728.
25. Pouny, Y., Rapaport, D., Mor, A., Nicolas, P., and Shai, Y. Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranes. Biochemistry, 31, 12416-12423.
26. Shai, Y. (1999) Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell nonselective membrane-lytic peptides. Biochim. Biophys. Acta, 1462, 55-70.
27. Matsuzaki, K. (2009) Control of cell selectivity of antimicrobial peptides. Biochim. Biophys. Acta, 1788, 1687-1692.
28. Yeaman, M.R. and Yount, N.Y. (2003) Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev., 55, 27-55.
29. Rotem, S. and Mor, A. (2009) Antimicrobial peptide mimics for improved therapeutic properties. Biochim. Biophys. Acta, 1788, 1582-1592.
30. Kondejewski, L.H., Farmer, S.W., Wishart, D.S., Kay, C.M., Hancock, R.E.W., and Hodges, R.S. (1996) Modulation of structure and antibacterial and hemolytic activity by ring size in cyclic gramicidin S analogs. J. Biol. Chem., 271, 25261-25268.
31. Kondejewski, L.H., Jelokhani-Niaraki, M., Farmer, S.W., Lix, B., Kay, C.M., Sykes, B.D., Hancock, R.E.W., and Hodges, R.S. (1999) Dissociation of antimicrobial and hemolytic activities in cyclic peptide diastereomers by systematic alterations in amphipathicity. J. Biol. Chem., 274, 13181-13192.
32. Mc Innes, C., Kondejewski, L.H., Hodges, R.S., and Sykes, B.D. (2000) Development of the structural basis for antimicrobial and hemolytic activities of peptides based on gramicidin S and design of novel analogs using NMR spectroscopy. J. Biol. Chem., 275, 14287-14294.
33. Zhang, L., Falla, T., Wu, M., Fidai, S., Burian, J., Kay, W., and Hancock, R.E.W. (1998) Determinants of recombinant production of antimicrobial cationic peptides and creation of peptide variants in bacteria. Biochem. Biophys. Res. Commun., 247, 674-680.
34. Zhang, L., Benz, R., and Hancock, R.E.W. (1999) Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides. Biochemistry, 38, 8102-8111.
35. Mant, C.T., Chen, Y., and Hodges, R.S. (2003) Temperature profiling of polypeptides in reversed-phase liquid chromatography. I. Monitoring of dimerization and unfolding of amphipathic alpha-helical peptides. J. Chromatogr. A, 1009, 29-43.
36. Lee, D.L., Mant, C.T., and Hodges, R.S. (2003) A novel method to measure selfassociation of small amphipathic molecules: temperature profiling in reversed-phase chromatography. J. Biol. Chem., 278, 22918-22927.
37. Chen, Y., Mant, C.T., and Hodges, R.S. (2002) Determination of stereochemistry stability coefficients of amino acid sidechains in an amphipathic alpha-helix. J. Pept. Res., 59, 18-33.
38. Monera, O.D., Sereda, T.J., Zhou, N.E., Kay, C.M., and Hodges, R.S. (1995) Relationship of sidechain hydrophobicity and alpha-helical propensity on the stability of the single-stranded amphipathic alpha-helix. J. Pept. Sci., 1, 319-329.
39. Kovacs, J.M., Mant, C.T., and Hodges, R.S. (2006) Determination of intrinsic hydrophilicity/hydrophobicity of amino acid side chains in peptides in the absence of nearest-neighbor or conformational effects. Biopolymers (Peptide Science), 84, 283-297.
40. Mant, C.T., Kovacs, J.M., Kim, H.M., Pollock, D.D., and Hodges, R.S. (2009) Intrinsic amino acid side-chain hydrophilicity/hydrophobicity coefficients determined by reversedphase high-performance liquid chromatography of model peptides: comparison with other hydrophilicity/hydrophobicity scales. Biopolymers (Peptide Science), 92, 573-595.
41. Zhou, N.E., Monera, O.D., Kay, C.M., and Hodges, R.S. (1994) a-Helical propensities of amino acids in the hydrophobic face of an amphipathic a-helix. Protein. Pept. Lett., 15, 238-243.
42. Zhang, L. and Falla, T.J. (2006) Antimicrobial peptides: therapeutic potential. Expert. Opin. Pharmacother., 7, 653-663.
43. Hancock, R.E.W. and Sahl, H.G. (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol., 24, 1551-1557.
44. Hirsch, T., Jacobsen, F., Steinau, H.U., and Steinstraesser, L. (2008) Host defense peptides and the new line of defence against multiresistant infections. Protein. Pept. Lett., 15, 238-243.
45. Pathan, F.K., Venkata, D.A., and Panguluri, S.K. (2010) Recent patents on antimicrobial peptides. Recent. Pat. DNA Gene Seq., 4, 10-16.
46. da Rocha Pitta, M.G. and Galdino, S.L. (2010) Development of novel therapeutic drugs in humans from plant antimicrobial peptides. Curr. Protein Pept. Sci., 11, 236-247.